During his career, he has led operations, strategic projects and asset transfers on behalf of various pharmaceutical companies, such as Bristol-Myers Squibb, Solvay Pharmaceuticals and Fournier Pharma. Dr. Tahiri has also been in charge of EU-wide business development and partnership projects between Life Science customers as part of Recipharm A.B., a leading contract development and manufacturing organisation (both in terms of start-ups and mid-size pharmaceutical companies). As head of pharmaceutical affairs and as a “responsible Pharmacist” in a biopharma, Dr. Tahiri created a licensed pharmaceutical company and lead interactions with various national health authorities, bridging drug candidate development with Early Access programs. He is also in charge of the clinical development of several compounds.
In 2020, Dr. Tahiri founded Health Economia, a consulting firm supporting investors, board structures and Life Science management teams, to steer Life Science assets.
Dr. Tahiri is trained as a Doctor of Pharmacy at Montpellier University (1999), France. He also holds an MBA from Burgundy Business School (2012), France, and a Finance Certificate from IMD Lausanne (2018) in Switzerland. He is a native speaker of Arabic, and is also fluent in French and English.